300 related articles for article (PubMed ID: 27255691)
1. Cataract surgery in patients with neovascular age-related macular degeneration.
Kessel L; Koefoed Theil P; Lykke Sørensen T; Munch IC
Acta Ophthalmol; 2016 Dec; 94(8):755-760. PubMed ID: 27255691
[TBL] [Abstract][Full Text] [Related]
2. Phacoemulsification in eyes with neovascular AMD treated with anti-VEGF injections.
Muzyka-Wozniak M
Eur J Ophthalmol; 2011; 21(6):766-70. PubMed ID: 21360482
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of cataract surgery in patients with neovascular age-related macular degeneration in the era of anti-vascular endothelial growth factor therapy.
Tabandeh H; Chaudhry NA; Boyer DS; Kon-Jara VA; Flynn HW
J Cataract Refract Surg; 2012 Apr; 38(4):677-82. PubMed ID: 22284725
[TBL] [Abstract][Full Text] [Related]
4. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
Veloso CE; Kanadani TM; Pereira FB; Nehemy MB
Ophthalmology; 2015 Aug; 122(8):1569-72. PubMed ID: 26038338
[TBL] [Abstract][Full Text] [Related]
5. Anti-Vascular Endothelial Growth Factor Intravitreal Therapy and Macular Ganglion Cell Layer Thickness in Patients with Neovascular Age-Related Macular Degeneration.
Abdolrahimzadeh S; Gharbiya M; Formisano M; Bertini F; Cerini A; Pacella E
Curr Eye Res; 2019 Sep; 44(9):1000-1005. PubMed ID: 30999772
[No Abstract] [Full Text] [Related]
6. Short-term results of switchback from aflibercept to ranibizumab in neovascular age-related macular degeneration in clinical practice.
Despreaux R; Cohen SY; Semoun O; Zambrowski O; Jung C; Oubraham H; Souied EH
Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):639-44. PubMed ID: 26092633
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Cataract Surgery in Patients With Exudative Age-related Macular Degeneration and Macular Fluid.
Starr MR; Mahr MA; Barkmeier AJ; Iezzi R; Smith WM; Bakri SJ
Am J Ophthalmol; 2018 Aug; 192():91-97. PubMed ID: 29802819
[TBL] [Abstract][Full Text] [Related]
8. NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH ADVANCED VISUAL LOSS TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: Clinical Outcome and Prognostic Indicators.
Vogel RN; Davis DB; Kimura BH; Rathinavelu S; Graves GS; Szabo A; Han DP
Retina; 2017 Feb; 37(2):257-264. PubMed ID: 27429385
[TBL] [Abstract][Full Text] [Related]
9. Cataract surgery in ranibizumab-treated patients with neovascular age-related macular degeneration from the phase 3 ANCHOR and MARINA trials.
Rosenfeld PJ; Shapiro H; Ehrlich JS; Wong P;
Am J Ophthalmol; 2011 Nov; 152(5):793-8. PubMed ID: 21794843
[TBL] [Abstract][Full Text] [Related]
10. Responses of Types 1 and 2 Neovascularization in Age-Related Macular Degeneration to Anti-Vascular Endothelial Growth Factor Treatment: Optical Coherence Tomography Angiography Analysis.
Kim JM; Cho HJ; Kim Y; Jung SH; Lee DW; Kim JW
Semin Ophthalmol; 2019; 34(3):168-176. PubMed ID: 31132283
[No Abstract] [Full Text] [Related]
11. Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational Study.
Gillies MC; Nguyen V; Daien V; Arnold JJ; Morlet N; Barthelmes D
Ophthalmology; 2016 Dec; 123(12):2545-2553. PubMed ID: 27707549
[TBL] [Abstract][Full Text] [Related]
12. Macular atrophy in patients with long-term anti-VEGF treatment for neovascular age-related macular degeneration.
Munk MR; Ceklic L; Ebneter A; Huf W; Wolf S; Zinkernagel MS
Acta Ophthalmol; 2016 Dec; 94(8):e757-e764. PubMed ID: 27417506
[TBL] [Abstract][Full Text] [Related]
13. Cataract surgery in neovascular AMD: impact on visual acuity and disease activity.
Tang HY; Rosén M; Granstam E
BMC Ophthalmol; 2023 Jun; 23(1):276. PubMed ID: 37328798
[TBL] [Abstract][Full Text] [Related]
14. Retinal Ganglion Cell Layer Change in Patients Treated With Anti-Vascular Endothelial Growth Factor for Neovascular Age-related Macular Degeneration.
Beck M; Munk MR; Ebneter A; Wolf S; Zinkernagel MS
Am J Ophthalmol; 2016 Jul; 167():10-7. PubMed ID: 27084000
[TBL] [Abstract][Full Text] [Related]
15. The effects of cataract surgery on patients with wet macular degeneration.
Saraf SS; Ryu CL; Ober MD
Am J Ophthalmol; 2015 Sep; 160(3):487-492.e1. PubMed ID: 26095263
[TBL] [Abstract][Full Text] [Related]
16. Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis.
Souied EH; Dugel PU; Ferreira A; Hashmonay R; Lu J; Kelly SP
Ophthalmic Epidemiol; 2016; 23(2):71-9. PubMed ID: 26855278
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes in eyes receiving fixed-interval dosing of anti-vascular endothelial growth factor agents for wet age-related macular degeneration.
Peden MC; Suñer IJ; Hammer ME; Grizzard WS
Ophthalmology; 2015 Apr; 122(4):803-8. PubMed ID: 25596618
[TBL] [Abstract][Full Text] [Related]
18. Super-dose anti-VEGF (SAVE) trial: 2.0 mg intravitreal ranibizumab for recalcitrant neovascular macular degeneration-primary end point.
Brown DM; Chen E; Mariani A; Major JC;
Ophthalmology; 2013 Feb; 120(2):349-54. PubMed ID: 23131717
[TBL] [Abstract][Full Text] [Related]
19. Variants in the VEGFA gene and treatment outcome after anti-VEGF treatment for neovascular age-related macular degeneration.
Abedi F; Wickremasinghe S; Richardson AJ; Makalic E; Schmidt DF; Sandhu SS; Baird PN; Guymer RH
Ophthalmology; 2013 Jan; 120(1):115-21. PubMed ID: 23149126
[TBL] [Abstract][Full Text] [Related]
20. Switch to Aflibercept in the Treatment of Neovascular AMD: One-Year Results in Clinical Practice.
Pinheiro-Costa J; Costa JM; Beato JN; Freitas-da-Costa P; Brandão E; Falcão MS; Falcão-Reis F; Carneiro ÂM
Ophthalmologica; 2015; 233(3-4):155-61. PubMed ID: 25896317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
